These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3320181)

  • 21. Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.
    Depew W; Boyer T; Omata M; Redeker A; Reynolds T
    Gastroenterology; 1980 Mar; 78(3):524-9. PubMed ID: 6985881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alcoholic hepatitis: clinicopathologic features and therapy.
    Maddrey WC
    Semin Liver Dis; 1988 Feb; 8(1):91-102. PubMed ID: 2834829
    [No Abstract]   [Full Text] [Related]  

  • 23. Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.
    Fujiwara K; Ogata I; Oka H
    Gastroenterol Jpn; 1989 Apr; 24(2):143-8. PubMed ID: 2472994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients.
    Shumaker JB; Resnick RH; Galambos JT; Makopour H; Iber FL
    Am J Gastroenterol; 1978 Apr; 69(4):443-9. PubMed ID: 356593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment.
    Larsen J; Hylleberg B; Ng K; Damsbo P
    Diabetes Care; 2001 Aug; 24(8):1416-21. PubMed ID: 11473079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective randomized clinical trial of peripheral amino acid-glucose supplementation in acute alcoholic hepatitis.
    Achord JL
    Am J Gastroenterol; 1987 Sep; 82(9):871-5. PubMed ID: 3307390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New trends in the therapy of alcoholic hepatic diseases].
    Tarantino G; Di Bernardo C; Vitaglione R; Cambri S
    Clin Ter; 1984 May; 109(3):243-58. PubMed ID: 6203679
    [No Abstract]   [Full Text] [Related]  

  • 29. Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis.
    Bird GL; Prach AT; McMahon AD; Forrest JA; Mills PR; Danesh BJ
    J Hepatol; 1998 Feb; 28(2):194-8. PubMed ID: 9514531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of the effects of insulin/glucagon infusions, parenteral amino acids and high dose corticosteroids on survival in a rabbit model of acute fulminant hepatitis.
    Minuk GY; Sherman TA; Shaffer EA; Kelly SK
    Hepatology; 1986; 6(1):73-8. PubMed ID: 3510952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatotrophic factors: basic concepts and clinical implications.
    Baker AL
    Acta Med Scand Suppl; 1985; 703():201-8. PubMed ID: 3911740
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.
    Stewart S; Prince M; Bassendine M; Hudson M; James O; Jones D; Record C; Day CP
    J Hepatol; 2007 Aug; 47(2):277-83. PubMed ID: 17532088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of hepatic steatosis in rats by addition of glucagon to total parenteral nutrition (TPN).
    Li SJ; Nussbaum MS; McFadden DW; Dayal R; Fischer JE
    J Surg Res; 1989 Jun; 46(6):557-66. PubMed ID: 2499733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of acute alcoholic alcoholism].
    Michel H; Larrey D; Blanc P
    Ann Gastroenterol Hepatol (Paris); 1993; 29(1):29-39. PubMed ID: 7680191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized control trial of lipo-prostaglandin E1 in patients with acute liver injury induced by lipiodol-targeted chemotherapy.
    Ikegami T; Matsuzaki Y; Kurusu J; Yoshiga S; Saito Y; Chiba T; Abei M; Shoda J; Tanaka N; Osuga T
    Clin Pharmacol Ther; 1995 May; 57(5):582-9. PubMed ID: 7768081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
    Castaldi C; D'Amore F; Materia E; Mauceri M; Rivosecchi L
    Minerva Cardioangiol; 1978 Nov; 26(11):751-6. PubMed ID: 724124
    [No Abstract]   [Full Text] [Related]  

  • 38. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.
    Akriviadis E; Botla R; Briggs W; Han S; Reynolds T; Shakil O
    Gastroenterology; 2000 Dec; 119(6):1637-48. PubMed ID: 11113085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoacid therapy of alcoholic hepatitis.
    Nasrallah SM; Galambos JT
    Lancet; 1980 Dec; 2(8207):1276-7. PubMed ID: 6108449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
    Sharma P; Kumar A; Sharma BC; Sarin SK
    J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.